Biotage AB Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | Biotage AB

Biotage AB | Cash Flow

Fiscal year is January-December. All values SEK Thousands.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

40,369.00

54,861.00

76,190.00

92,401.00

136,260.00

176,289

Depreciation, Depletion & Amortization

31,864.00

40,679.00

34,679.00

34,225.00

39,412

Other Funds

160.00

21,041

Funds from Operations

68,511.00

95,384.00

120,473.00

129,687.00

167,385.00

194,660

Changes in Working Capital

11,755.00

14,478.00

395.00

9,384.00

1,547.00

39,655

Net Operating Cash Flow

56,756.00

80,906.00

120,078.00

139,071.00

168,932.00

155,005

Capital Expenditures

41,327.00

32,177.00

32,029.00

47,540.00

37,804.00

Purchase/Sale of Investments

144.00

165.00

Net Investing Cash Flow

41,471.00

32,177.00

31,864.00

67,726.00

36,902.00

Cash Dividends Paid - Total

34,931.00

38,829.00

48,536.00

80,893.00

Issuance/Reduction of Debt, Net

66.00

2,503.00

6,698.00

259.00

Net Financing Cash Flow

95,095.00

41,425.00

55,234.00

81,152.00

81,053.00

Net Change in Cash

80,147.00

9,276.00

34,841.00

6,263.00

45,641.00

Free Cash Flow

47,941.00

72,139.00

109,244.00

125,853.00

158,126.00

Other Sources

435.00

902.00

Change in Capital Stock

60,230.00

93.00

Exchange Rate Effect

337.00

1,972.00

1,861.00

3,544.00

5,336.00

Other Uses

20,621.00

About Biotage AB

View Profile

Address	Vimpelgatan 5 Uppsala UP 753 18 Sweden
Employees	-
Website	http://www.biotage.com
Updated	07/08/2019
Biotage AB engages in the provision of separation and synthesis technology solutions. Its products include equipment for chromatography and purification, organic synthesis, analytical sample preparation, evaporation and concentration, peptide synthesis, and custom projects. The company was founded by Pal Nyrén, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Bertil Pettersson, Neil Goldsmith and Björn Ekström in 1997 and is headquartered in Uppsala, Sweden.